Companies / BOC Sciences / Retifanlimab
BOC Sciences

Retifanlimab | BOC Sciences

Retifanlimab is an anti-PD-1 monoclonal antibody. Retifanlimab has been used as a mediacation for the treatment of Merkel cell carcinoma.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.